世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antiviral Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3845 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、抗ウイルス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他）、用途別市場規模（病院、診療所、外来手術センター、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗ウイルス療法の市場動向 ・企業の競争状況、市場シェア ・抗ウイルス療法の種類別市場規模と予測2016-2027（ヘルペス抗ウイルス薬、肝炎抗ウイルス薬、HIV抗ウイルス薬、インフルエンザ抗ウイルス薬、その他） ・抗ウイルス療法の用途別市場規模と予測2016-2027（病院、診療所、外来手術センター、薬局、その他） ・抗ウイルス療法の北米市場規模2016-2027（アメリカ、カナダ） ・抗ウイルス療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗ウイルス療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗ウイルス療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗ウイルス療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc.、GSK、Boehringer Ingelheim、Merck、Novartis、Beximco Pharmaceuticals、Pfizer、Roche、Bristol-Myers Squibb Company、Johnson & Johnson、Sanofi） ・結論

Market Analysis and Insights: Global Antiviral Therapeutics Market
The global Antiviral Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiviral Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiviral Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiviral Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiviral Therapeutics market.

Global Antiviral Therapeutics Scope and Market Size
Antiviral Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Herpes Antiviral Drugs
Hepatitis Antiviral Drugs
HIV Antiviral Drugs
Influenza Antiviral Drugs
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc.
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Bristol-Myers Squibb Company
Johnson & Johnson
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Herpes Antiviral Drugs
1.2.3 Hepatitis Antiviral Drugs
1.2.4 HIV Antiviral Drugs
1.2.5 Influenza Antiviral Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Antiviral Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiviral Therapeutics Market Perspective (2016-2027)
2.2 Antiviral Therapeutics Growth Trends by Regions
2.2.1 Antiviral Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiviral Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Antiviral Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Antiviral Therapeutics Industry Dynamic
2.3.1 Antiviral Therapeutics Market Trends
2.3.2 Antiviral Therapeutics Market Drivers
2.3.3 Antiviral Therapeutics Market Challenges
2.3.4 Antiviral Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiviral Therapeutics Players by Revenue
3.1.1 Global Top Antiviral Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Antiviral Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Antiviral Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiviral Therapeutics Revenue
3.4 Global Antiviral Therapeutics Market Concentration Ratio
3.4.1 Global Antiviral Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Therapeutics Revenue in 2020
3.5 Antiviral Therapeutics Key Players Head office and Area Served
3.6 Key Players Antiviral Therapeutics Product Solution and Service
3.7 Date of Enter into Antiviral Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiviral Therapeutics Breakdown Data by Type
4.1 Global Antiviral Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Antiviral Therapeutics Forecasted Market Size by Type (2022-2027)

5 Antiviral Therapeutics Breakdown Data by Application
5.1 Global Antiviral Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Antiviral Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antiviral Therapeutics Market Size (2016-2027)
6.2 North America Antiviral Therapeutics Market Size by Type
6.2.1 North America Antiviral Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Antiviral Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Antiviral Therapeutics Market Size by Type (2016-2027)
6.3 North America Antiviral Therapeutics Market Size by Application
6.3.1 North America Antiviral Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Antiviral Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Antiviral Therapeutics Market Size by Application (2016-2027)
6.4 North America Antiviral Therapeutics Market Size by Country
6.4.1 North America Antiviral Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Antiviral Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antiviral Therapeutics Market Size (2016-2027)
7.2 Europe Antiviral Therapeutics Market Size by Type
7.2.1 Europe Antiviral Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Antiviral Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Antiviral Therapeutics Market Size by Type (2016-2027)
7.3 Europe Antiviral Therapeutics Market Size by Application
7.3.1 Europe Antiviral Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Antiviral Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Antiviral Therapeutics Market Size by Application (2016-2027)
7.4 Europe Antiviral Therapeutics Market Size by Country
7.4.1 Europe Antiviral Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Antiviral Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antiviral Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Antiviral Therapeutics Market Size by Type
8.2.1 Asia-Pacific Antiviral Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiviral Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiviral Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiviral Therapeutics Market Size by Application
8.3.1 Asia-Pacific Antiviral Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiviral Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiviral Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiviral Therapeutics Market Size by Region
8.4.1 Asia-Pacific Antiviral Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiviral Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antiviral Therapeutics Market Size (2016-2027)
9.2 Latin America Antiviral Therapeutics Market Size by Type
9.2.1 Latin America Antiviral Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Antiviral Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Antiviral Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Antiviral Therapeutics Market Size by Application
9.3.1 Latin America Antiviral Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Antiviral Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Antiviral Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Antiviral Therapeutics Market Size by Country
9.4.1 Latin America Antiviral Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Antiviral Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antiviral Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Antiviral Therapeutics Market Size by Type
10.2.1 Middle East & Africa Antiviral Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiviral Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiviral Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiviral Therapeutics Market Size by Application
10.3.1 Middle East & Africa Antiviral Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiviral Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiviral Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiviral Therapeutics Market Size by Country
10.4.1 Middle East & Africa Antiviral Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiviral Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Antiviral Therapeutics Introduction
11.1.4 AbbVie Inc. Revenue in Antiviral Therapeutics Business (2016-2021)
11.1.5 AbbVie Inc. Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Antiviral Therapeutics Introduction
11.2.4 GSK Revenue in Antiviral Therapeutics Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Antiviral Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Therapeutics Introduction
11.4.4 Merck Revenue in Antiviral Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antiviral Therapeutics Introduction
11.5.4 Novartis Revenue in Antiviral Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Beximco Pharmaceuticals
11.6.1 Beximco Pharmaceuticals Company Details
11.6.2 Beximco Pharmaceuticals Business Overview
11.6.3 Beximco Pharmaceuticals Antiviral Therapeutics Introduction
11.6.4 Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2016-2021)
11.6.5 Beximco Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antiviral Therapeutics Introduction
11.7.4 Pfizer Revenue in Antiviral Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Antiviral Therapeutics Introduction
11.8.4 Roche Revenue in Antiviral Therapeutics Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Antiviral Therapeutics Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2016-2021)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Antiviral Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Antiviral Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Antiviral Therapeutics Introduction
11.11.4 Sanofi Revenue in Antiviral Therapeutics Business (2016-2021)
11.11.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antiviral Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Herpes Antiviral Drugs
Table 3. Key Players of Hepatitis Antiviral Drugs
Table 4. Key Players of HIV Antiviral Drugs
Table 5. Key Players of Influenza Antiviral Drugs
Table 6. Key Players of Others
Table 7. Global Antiviral Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antiviral Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antiviral Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Antiviral Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Antiviral Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Antiviral Therapeutics Market Share by Regions (2022-2027)
Table 13. Antiviral Therapeutics Market Trends
Table 14. Antiviral Therapeutics Market Drivers
Table 15. Antiviral Therapeutics Market Challenges
Table 16. Antiviral Therapeutics Market Restraints
Table 17. Global Antiviral Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Antiviral Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Therapeutics as of 2020)
Table 20. Ranking of Global Top Antiviral Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Antiviral Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antiviral Therapeutics Product Solution and Service
Table 24. Date of Enter into Antiviral Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Antiviral Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Antiviral Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Antiviral Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Antiviral Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Antiviral Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Antiviral Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Antiviral Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Antiviral Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Antiviral Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Antiviral Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Antiviral Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Antiviral Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Antiviral Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Antiviral Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Antiviral Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Antiviral Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Antiviral Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antiviral Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antiviral Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Antiviral Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Antiviral Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Antiviral Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Antiviral Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Antiviral Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Antiviral Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Antiviral Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Antiviral Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antiviral Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antiviral Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antiviral Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Antiviral Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Antiviral Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Antiviral Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. AbbVie Inc. Company Details
Table 65. AbbVie Inc. Business Overview
Table 66. AbbVie Inc. Antiviral Therapeutics Product
Table 67. AbbVie Inc. Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 68. AbbVie Inc. Recent Development
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK Antiviral Therapeutics Product
Table 72. GSK Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 73. GSK Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Antiviral Therapeutics Product
Table 77. Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Antiviral Therapeutics Product
Table 82. Merck Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Antiviral Therapeutics Product
Table 87. Novartis Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Beximco Pharmaceuticals Company Details
Table 90. Beximco Pharmaceuticals Business Overview
Table 91. Beximco Pharmaceuticals Antiviral Therapeutics Product
Table 92. Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Beximco Pharmaceuticals Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Antiviral Therapeutics Product
Table 97. Pfizer Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Roche Recent Development
Table 103. Bristol-Myers Squibb Company Company Details
Table 104. Bristol-Myers Squibb Company Business Overview
Table 105. Bristol-Myers Squibb Company Antiviral Therapeutics Product
Table 106. Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Bristol-Myers Squibb Company Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Antiviral Therapeutics Product
Table 111. Johnson & Johnson Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Johnson & Johnson Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Antiviral Therapeutics Product
Table 116. Sanofi Revenue in Antiviral Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Herpes Antiviral Drugs Features
Figure 3. Hepatitis Antiviral Drugs Features
Figure 4. HIV Antiviral Drugs Features
Figure 5. Influenza Antiviral Drugs Features
Figure 6. Others Features
Figure 7. Global Antiviral Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Antiviral Therapeutics Report Years Considered
Figure 14. Global Antiviral Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Antiviral Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Antiviral Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Antiviral Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Antiviral Therapeutics Market Share by Players in 2020
Figure 19. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Antiviral Therapeutics Revenue in 2020
Figure 21. Global Antiviral Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Antiviral Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Antiviral Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Antiviral Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Antiviral Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Antiviral Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Antiviral Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Antiviral Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Antiviral Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Antiviral Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Antiviral Therapeutics Market Share by Region (2016-2027)
Figure 43. China Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Antiviral Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Antiviral Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Antiviral Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Antiviral Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Antiviral Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Antiviral Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Antiviral Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. AbbVie Inc. Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 67. Beximco Pharmaceuticals Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 71. Johnson & Johnson Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Antiviral Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---